Early Reduction of MRI Activity During 6 Months of Treatment With Cladribine Tablets for Highly Active Relapsing Multiple Sclerosis: MAGNIFY-MS.
| Autor: | de Stefano, Nicola, Barkhof, Frederik, Montalban, Xavier, Achiron, Anat, Derfuss, Tobias, Chan, Andrew, Hodgkinson, Suzanne, Prat, Alexandre, Leocani, Letizia, Schmierer, Klaus, Sellebjerg, Finn, Vermersch, Patrick, Wiendl, Heinz, Keller, Birgit, Roy, Sanjeev |
|---|---|
| Zdroj: | Neurology® Neuroimmunology & Neuroinflammation; Jul2022, Vol. 9 Issue 4, p1-10, 10p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|